Author:
Dhawan P,Ahmad R,Chaturvedi R,Smith J J,Midha R,Mittal M K,Krishnan M,Chen X,Eschrich S,Yeatman T J,Harris R C,Washington M K,Wilson K T,Beauchamp R D,Singh A B
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference54 articles.
1. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Söderholm JD, Zeitz M et al. (2009). Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44: 1226–1235.
2. Angelow S, Schneeberger EE, Yu AS . (2007). Claudin-8 expression in renal epithelial cells augments the paracellular barrier by replacing endogenous claudin-2. J Membr Biol 215: 147–159.
3. Ansfield F, Klotz J, Nealon T, Ramirez G, Minton J, Hill G et al. (1977). A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report. Cancer 39: 34–40.
4. Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J . (1997). PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 3: 2099–2106.
5. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V et al. (2010). Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci USA 107: 2628–2633.
Cited by
137 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献